# Lipid Mediators in Multiple Sclerosis

> **NCT03492606** · — · COMPLETED · sponsor: **Neuromed IRCCS** · enrollment: 150 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **PROCEDURE:** Samples

## Key facts

- **NCT ID:** NCT03492606
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2020-09-09
- **Final completion:** 2021-01-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03492606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03492606, "Lipid Mediators in Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03492606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*